About This Fund
Nordic Capital Evolution Fund (Evolution I) is a €1.2 billion mid-market private equity buyout fund managed by Nordic Capital, a leading sector-specialist private equity firm with a 35-year operational history across the Nordic and Northern European markets. Reaching final close on July 1, 2021, in a record fundraising period of just three months, Evolution I is the inaugural fund in Nordic Capital's dedicated mid-market vehicle series, designed to apply the firm's proven large-cap value creation model to a broader universe of mid-sized European companies. The fund closed at the hard cap and was significantly oversubscribed.
Evolution Fund targets control buyout investments in mid-market companies across Northern Europe, with equity commitments typically ranging from EUR 35 million to EUR 150 million and enterprise values of EUR 50 million to EUR 300 million. The fund concentrates on three core sectors aligned with Nordic Capital's institutional expertise: Healthcare; Technology & Payments; and Financial Services. Building on the same value creation toolkit deployed in Nordic Capital's flagship buyout series—emphasising digital transformation, talent development, internationalisation, and operational efficiency—Evolution I seeks to capture structural growth opportunities in the Northern European mid-market, a segment historically underserved by dedicated large-cap buyout vehicles of equivalent quality.
The fund attracted a geographically well-diversified institutional investor base with European LPs representing approximately 57% of commitments, followed by Asian investors at 19%, North American investors at 19%, and Middle Eastern investors at approximately 5%. By investor type, asset managers and advisers represent roughly 40%, public and private pension funds 30%, sovereign wealth funds 20%, and endowments and family offices 10%. Evolution I proved the concept for a standalone mid-market series: its successor, Nordic Capital Evolution II, closed at the EUR 2 billion hard cap in December 2024, 65% larger and raised within just four months, confirming deep institutional demand for the strategy.